New - European Medical Journal

Continue

News

New COVID-19 Vaccine Candidate Generates Neutralising Antibodies
Allergy & Immunology
6 Apr 2020

New COVID-19 Vaccine Candidate Generates Neutralising Antibodies

A VACCINE candidate for COVID-19 has shown promise in mice studies by producing antibodies specific to SARS-CoV-2, at levels thought to be sufficient…
Could Ivermectin be an Effective COVID-19 Treatment?
Respiratory
6 Apr 2020

Could Ivermectin be an Effective COVID-19 Treatment?

IVERMECTIN, an antiparasitic drug that is in use around the world, has shown to kill the SARS-CoV-2 virus within 48 hours…
Rheumatology
2 Apr 2020

Rheumatoid Arthritis Drug to be Repurposed for COVID-19 Therapy in Phase II/III Clinical Trial

The U.S. Department of Human Health and Services’ (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR)…
pandemic
General Healthcare
2 Apr 2020

COVID-19 Pandemic Knowledge Course

ES4P’s David Joyce, MD, MBA, and Scott Parazynski, MD, Partner to Offer New Course on Coronavirus Disease (COVID-19)…
General Healthcare
1 Apr 2020

Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19

Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19; Landmark New Partnership with U.S…
parking image
General Healthcare
1 Apr 2020

GMB Calls for the Extension of Free Parking for NHS Staff Indefinitely

GMB, the Union for NHS staff, has called for the indefinite extension of the UK governments scheme to suspend NHS staff parking…
National Rosacea Society Reveals New Guidelines on Standard Treatment Options for Rosacea
Dermatology
31 Mar 2020

National Rosacea Society Reveals New Guidelines on Standard Treatment Options for Rosacea

GUIDELINES for the standard treatment options of rosacea, including recommendations for oral therapies, topical therapies, and light-based devices…
New At-Risk Group Identified for Early Melanoma Diagnosis and Treatment
Dermatology
31 Mar 2020

New At-Risk Group Identified for Early Melanoma Diagnosis and Treatment

EVERY YEAR, 197,000 melanoma diagnoses are made globally, and in the UK alone the malignancy constitutes approximately 5% of cancer cases…
We’ve noticed you’re accessing
from North/South America.